Vascular endothelial growth factor A - PDFSEARCH.IO - Document Search Engine

Vascular endothelial growth factor A
Results: 127

#	Item
81	2014 EDITORIAL CALENDAR: THE BEST IN CLINICAL INSIGHTS, 12 TIMES A YEAR January February March Add to Reading List Source URL: www.aao.org Language: English - Date: 2014-04-04 16:18:30 Blindness Glaucoma Uveitis Vascular endothelial growth factor Eye disease Macular edema Intraocular lens Cataract Wills Eye Institute Ophthalmology Health Medicine
82	Bayer: Innovation & Sustainability 2011 Our Mission Bayer: Science For A Better Life Add to Reading List Source URL: www.us-algeria.org Language: English - Date: 2011-06-23 11:34:37 Organofluorides Angiology Orphan drugs Vascular endothelial growth factor Riociguat Sorafenib Alpharadin Bayer Angiogenesis Medicine Chemistry Organic chemistry
83	Validation of a ToxCast Predictive Signature for Vascular Disruption in a Human Cell Based Angiogenesis Assay Nicole C. Kleinstreuer1, Riina Sarkanen2, Tuula Heinonen2, Thomas B. Knudsen1 1U.S. EPA/ORD/NCCT, RTP, NC, US Add to Reading List Source URL: www.epa.gov Language: English - Date: 2013-04-10 16:29:05 Medicine Angiogenesis Vascular endothelial growth factor Vasculogenesis Endothelium Assay Platelet-derived growth factor Proteases in angiogenesis Angiology Biology Anatomy
84	A second-generation antisense drug. Antisense drugs are RNA (similar to DNA, but single stranded) that inactivates other messenger RNA strands (known as mRNA). These drugs are short sequences of RNA that attach to mRNA a Add to Reading List Source URL: www.icotherapeutics.com Language: English - Date: 2014-09-02 18:21:27 Macular degeneration Macular edema Diabetic retinopathy Antisense therapy Macula of retina Vascular endothelial growth factor Ophthalmology Vision Health
85	Most of the common treatments described here impact wet age-related macular degeneration (AMD). It is important to note that there is currently no specific treatment for dry macular degeneration; however, taking a specif Add to Reading List Source URL: www.brightfocus.org Language: English - Date: 2013-09-16 10:06:56 Health Bevacizumab Ranibizumab Macular degeneration Vascular endothelial growth factor Pegaptanib Presumed ocular histoplasmosis syndrome Genentech Angiogenesis inhibitor Medicine Angiology Ophthalmology
86	Inside PMB You Can’t Fool Mother Nature Mother Nature: Friend, Foe Seems like Mother Nature is having a go at us lately, and it is beginning to Add to Reading List Source URL: ctep.cancer.gov Language: English - Date: 2008-05-28 21:39:37 Cancer organizations Bevacizumab Drug discovery Paclitaxel Carboplatin Clinical trial Management of cancer National Cancer Institute Vascular endothelial growth factor Chemistry Medicine Organic chemistry
87	Volume 26 (4), 2006 Editors Barbara Cadario, B.Sc.(Honours), B.Sc.Phm., M.Sc. Karen L.A. Wlock, B.Sc.(Pharm.) Contents Add to Reading List Source URL: dpic.org Language: English - Date: 2013-06-09 23:30:14 Angiology Medical emergencies Blindness Ranibizumab Vascular endothelial growth factor Choroidal neovascularization Pegaptanib Macular degeneration Bevacizumab Medicine Health Ophthalmology
88	Regulation of gene expression by HIF-1 Gregg L. Semenza, Larissa A. Shimoda* and Nanduri R. Prabhakar† Vascular Program, Institute for Cell Engineering; Departments of Pediatrics, Medicine, Oncology, and Radiation Onco Add to Reading List Source URL: media.wiley.com Language: English - Date: 2007-10-05 17:12:00 Hypoxia-inducible factors Von Hippel–Lindau tumor suppressor HIF1A Hypoxia Vascular endothelial growth factor EP300 DBP Carotid body Hydroxylation Biology Transcription factors Medicine
89	FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee Marriott Inn and Conference Center University of Maryland University College (UMUC) A Add to Reading List Source URL: www.fda.gov Language: English Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Vascular endothelial growth factor Macular degeneration Q4 Ketorolac Medicine Pharmaceutical sciences Health
90	FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee Marriott Inn and Conference Center University of Maryland University College (UMUC) A Add to Reading List Source URL: www.fda.gov Language: English Vascular endothelial growth factor Dermatologic and Ophthalmic Drugs Advisory Committee University of Maryland University College Macular degeneration Biology Ketorolac Health Medicine Angiology Growth factors